FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3033180717> ?p ?o ?g. }

• W3033180717 endingPage "1294" @default.
• W3033180717 startingPage "1293" @default.
• W3033180717 abstract "Parkinson’s disease (PD) is a multisystem disease in which both the central nervous system (CNS) and peripheral nervous system (PNS) are affected. It is characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta as the result of abnormal accumulation and aggregation of α-synuclein (α-syn) in the form of Lewy bodies and Lewy neurites.1 α-Syn plays an important role in the pathogenesis of neurodegenerative diseases and is considered to be the pathological hallmark of PD and Lewy body dementia.2 α-Syn is expressed in neurons (both the CNS and PNS) as well as in erythrocytes and most immune cells. Indeed, several studies have shown that α-syn is upregulated after immune stimulation.3-5 Recent reports have shown significant deficiency in T cell development in α-syn knock-out mice, which implicates α-syn in both the development of B-lymphocytes6 and in regulation of T cell phenotypes and function. It has multiple immunomodulatory functions, which can promote disease pathogenicity and also offer protection against proinflammatory responses.7 In addition, it has been shown that α-syn can also facilitate immune reactions against infections.8 Moreover, yet little is known about the innate neuron-specific inhibitors of viral infections in the CNS. Neuronal expression of α-syn restricts the replication of RNA viruses and protects mice from virus-induced neuronal injury. By contrast, in the absence of α-syn, endoplasmic reticulum stress signaling was significantly altered in mice contaminated by neurotrophic RNA viruses, such as West Nile virus and Venezuelan equine encephalitis.3 This supports the hypothesis that α-syn may play an important role in immune defense responses.4 In addition, it has been hypothesized that the α-syn inhibits viral neuroinvasion from the PNS to the CNS.9 Microglia are the resident immune cells of the brain; they play a major role in the neuroinfilammatory process with a high phagocytic capacity.10 It has been shown that a reduction of the α-syn expression level in microglia highly increases their response to lipopolysaccharides, whereas it decreases their phagocytic ability.11 This is a consequence of overactivation of phospholipase D2 and cyclooxygenase-2, which suggests that α-syn is implicated in lipid-mediated signaling by microglia.12 Moreover, α-syn may be an activating extracellular ligand for microglia.12 This supports the findings mentioned previously in relation to its neuroprotective effect.3 Coronavirus 2019 (COVID-19) can infect neurons and cause disease.13 It has been shown that it induces neurological diseases such as polyneuropathy, encephalitis, aortic ischemic stroke, and other neurological diseases.14, 15 Neurological manifestations of COVID-19 infection have been classified into 2 categories: CNS and PNS manifestations. CNS symptoms include dizziness, headache, impaired consciousness, acute cerebrovascular disease, ataxia, and epilepsy. However, PNS symptoms are less severe and include hyposmia, hypoplasia, neuralgia, and hypogeusia.16 Taken together, the evidence noted previously suggests that the overexpression of α-syn in patients suffering from PD might prevent neuroinvasion by the coronavirus, possibly by inhibiting the spread of the virus from the PNS to the CNS. Consistent with this hypothesis, a retrospective cohort study conducted in Japan showed that patients with parkinsonism hospitalized for pneumonia had a lower rate of in-hospital mortality.17 This hypothesis can be confirmed by using a large cohort of patients with PD experiencing a severe acute respiratory syndrome attributed to COVID-19 infection. (1) Research Project: A. Conception, B. Organization, C. Execution; (2) Statistical Analysis: A. Design, B. Execution, C. Review and Critique; (3) Manuscript: A. Writing of the First Draft, B. Review and Critique. S.A.: 1A, 1B, 1C, 3A, 3B A.A.: 1A, 1B, 1C, 3A, 3B Z.O.: 1B, 1C, 3A, 3B M.E.: 1B, 3A, 3B A.B.: 1B, 3B M.N.: 1B, 3B" @default.
• W3033180717 created "2020-06-12" @default.
• W3033180717 creator A5002185483 @default.
• W3033180717 creator A5004256963 @default.
• W3033180717 creator A5023214340 @default.
• W3033180717 creator A5030049957 @default.
• W3033180717 creator A5074170068 @default.
• W3033180717 creator A5091370747 @default.
• W3033180717 date "2020-07-16" @default.
• W3033180717 modified "2023-10-16" @default.
• W3033180717 title "The Possible Protective Role of <scp>α‐Synuclein</scp> Against Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Patients With Parkinson's Disease" @default.
• W3033180717 cites W1563590122 @default.
• W3033180717 cites W1824088642 @default.
• W3033180717 cites W1832148330 @default.
• W3033180717 cites W1978578381 @default.
• W3033180717 cites W2044451951 @default.
• W3033180717 cites W2061471792 @default.
• W3033180717 cites W2212998809 @default.
• W3033180717 cites W2344880159 @default.
• W3033180717 cites W2519014298 @default.
• W3033180717 cites W2681281215 @default.
• W3033180717 cites W2752144640 @default.
• W3033180717 cites W2796353027 @default.
• W3033180717 cites W2892372962 @default.
• W3033180717 cites W2972589620 @default.
• W3033180717 cites W3013270768 @default.
• W3033180717 cites W3013896658 @default.
• W3033180717 cites W3020984757 @default.
• W3033180717 cites W3135253353 @default.
• W3033180717 doi "https://doi.org/10.1002/mds.28185" @default.
• W3033180717 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7300655" @default.
• W3033180717 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32519352" @default.
• W3033180717 hasPublicationYear "2020" @default.
• W3033180717 type Work @default.
• W3033180717 sameAs 3033180717 @default.
• W3033180717 citedByCount "36" @default.
• W3033180717 countsByYear W30331807172020 @default.
• W3033180717 countsByYear W30331807172021 @default.
• W3033180717 countsByYear W30331807172022 @default.
• W3033180717 countsByYear W30331807172023 @default.
• W3033180717 crossrefType "journal-article" @default.
• W3033180717 hasAuthorship W3033180717A5002185483 @default.
• W3033180717 hasAuthorship W3033180717A5004256963 @default.
• W3033180717 hasAuthorship W3033180717A5023214340 @default.
• W3033180717 hasAuthorship W3033180717A5030049957 @default.
• W3033180717 hasAuthorship W3033180717A5074170068 @default.
• W3033180717 hasAuthorship W3033180717A5091370747 @default.
• W3033180717 hasBestOaLocation W30331807171 @default.
• W3033180717 hasConcept C137183658 @default.
• W3033180717 hasConcept C142724271 @default.
• W3033180717 hasConcept C169760540 @default.
• W3033180717 hasConcept C203014093 @default.
• W3033180717 hasConcept C2776773494 @default.
• W3033180717 hasConcept C2776925932 @default.
• W3033180717 hasConcept C2777440831 @default.
• W3033180717 hasConcept C2779134260 @default.
• W3033180717 hasConcept C2779734285 @default.
• W3033180717 hasConcept C2780938664 @default.
• W3033180717 hasConcept C2780942790 @default.
• W3033180717 hasConcept C2781449126 @default.
• W3033180717 hasConcept C513476851 @default.
• W3033180717 hasConcept C71924100 @default.
• W3033180717 hasConcept C86803240 @default.
• W3033180717 hasConcept C8891405 @default.
• W3033180717 hasConceptScore W3033180717C137183658 @default.
• W3033180717 hasConceptScore W3033180717C142724271 @default.
• W3033180717 hasConceptScore W3033180717C169760540 @default.
• W3033180717 hasConceptScore W3033180717C203014093 @default.
• W3033180717 hasConceptScore W3033180717C2776773494 @default.
• W3033180717 hasConceptScore W3033180717C2776925932 @default.
• W3033180717 hasConceptScore W3033180717C2777440831 @default.
• W3033180717 hasConceptScore W3033180717C2779134260 @default.
• W3033180717 hasConceptScore W3033180717C2779734285 @default.
• W3033180717 hasConceptScore W3033180717C2780938664 @default.
• W3033180717 hasConceptScore W3033180717C2780942790 @default.
• W3033180717 hasConceptScore W3033180717C2781449126 @default.
• W3033180717 hasConceptScore W3033180717C513476851 @default.
• W3033180717 hasConceptScore W3033180717C71924100 @default.
• W3033180717 hasConceptScore W3033180717C86803240 @default.
• W3033180717 hasConceptScore W3033180717C8891405 @default.
• W3033180717 hasIssue "8" @default.
• W3033180717 hasLocation W30331807171 @default.
• W3033180717 hasLocation W30331807172 @default.
• W3033180717 hasLocation W30331807173 @default.
• W3033180717 hasLocation W30331807174 @default.
• W3033180717 hasOpenAccess W3033180717 @default.
• W3033180717 hasPrimaryLocation W30331807171 @default.
• W3033180717 hasRelatedWork W124530129 @default.
• W3033180717 hasRelatedWork W1977755660 @default.
• W3033180717 hasRelatedWork W2123207269 @default.
• W3033180717 hasRelatedWork W2144361218 @default.
• W3033180717 hasRelatedWork W2346291302 @default.
• W3033180717 hasRelatedWork W2371206107 @default.
• W3033180717 hasRelatedWork W2510621258 @default.
• W3033180717 hasRelatedWork W2602771706 @default.
• W3033180717 hasRelatedWork W3170435337 @default.
• W3033180717 hasRelatedWork W4297539645 @default.
• W3033180717 hasVolume "35" @default.

• next